IBDEI1DB ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21859,1,4,0)
 ;;=4^L97.916
 ;;^UTILITY(U,$J,358.3,21859,2)
 ;;=^5151488
 ;;^UTILITY(U,$J,358.3,21860,0)
 ;;=G20.^^99^1113^2
 ;;^UTILITY(U,$J,358.3,21860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21860,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,21860,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,21860,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,21861,0)
 ;;=I30.0^^99^1113^3
 ;;^UTILITY(U,$J,358.3,21861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21861,1,3,0)
 ;;=3^Pericarditis,idiopath,acute,nonspec
 ;;^UTILITY(U,$J,358.3,21861,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,21861,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,21862,0)
 ;;=I73.9^^99^1113^4
 ;;^UTILITY(U,$J,358.3,21862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21862,1,3,0)
 ;;=3^Peripheral vascular disease, unspec
 ;;^UTILITY(U,$J,358.3,21862,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,21862,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,21863,0)
 ;;=F60.89^^99^1113^5
 ;;^UTILITY(U,$J,358.3,21863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21863,1,3,0)
 ;;=3^Personality disorders,oth,spec
 ;;^UTILITY(U,$J,358.3,21863,1,4,0)
 ;;=4^F60.89
 ;;^UTILITY(U,$J,358.3,21863,2)
 ;;=^5003638
 ;;^UTILITY(U,$J,358.3,21864,0)
 ;;=I80.3^^99^1113^7
 ;;^UTILITY(U,$J,358.3,21864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21864,1,3,0)
 ;;=3^Phlebitis & thrombophlbts of low extrmties, unspec
 ;;^UTILITY(U,$J,358.3,21864,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,21864,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,21865,0)
 ;;=R09.1^^99^1113^9
 ;;^UTILITY(U,$J,358.3,21865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21865,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,21865,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,21865,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,21866,0)
 ;;=J91.8^^99^1113^8
 ;;^UTILITY(U,$J,358.3,21866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21866,1,3,0)
 ;;=3^Pleural effus in oth cond clsfd elsewhere
 ;;^UTILITY(U,$J,358.3,21866,1,4,0)
 ;;=4^J91.8
 ;;^UTILITY(U,$J,358.3,21866,2)
 ;;=^5008311
 ;;^UTILITY(U,$J,358.3,21867,0)
 ;;=J18.9^^99^1113^10
 ;;^UTILITY(U,$J,358.3,21867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21867,1,3,0)
 ;;=3^Pneumonia, unspec organism
 ;;^UTILITY(U,$J,358.3,21867,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,21867,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,21868,0)
 ;;=I49.3^^99^1113^13
 ;;^UTILITY(U,$J,358.3,21868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21868,1,3,0)
 ;;=3^Premature ventricular depolarization
 ;;^UTILITY(U,$J,358.3,21868,1,4,0)
 ;;=4^I49.3
 ;;^UTILITY(U,$J,358.3,21868,2)
 ;;=^5007233
 ;;^UTILITY(U,$J,358.3,21869,0)
 ;;=L40.4^^99^1113^15
 ;;^UTILITY(U,$J,358.3,21869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21869,1,3,0)
 ;;=3^Psoriasis Guttate
 ;;^UTILITY(U,$J,358.3,21869,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,21869,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,21870,0)
 ;;=L40.1^^99^1113^17
 ;;^UTILITY(U,$J,358.3,21870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21870,1,3,0)
 ;;=3^Psoriasis, generalized pustular
 ;;^UTILITY(U,$J,358.3,21870,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,21870,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,21871,0)
 ;;=L40.0^^99^1113^16
 ;;^UTILITY(U,$J,358.3,21871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21871,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,21871,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,21871,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,21872,0)
 ;;=L40.8^^99^1113^18
